After seeming to lose interest . . .

MedPAC Revisits Using 'Least Costly Alternative' Policy To Control Drug Prices

By John Wilkerson / October 8, 2015 at 8:34 PM
A few congressional Medicare advisers said they want to consider using CMS' stalled least-costly-alternative approach to control drug prices after seeming to lose interest in the controversial policy earlier this year. The goal of the Medicare Payment Advisory Commission meeting on Thursday (Oct. 8) was to determine the changes to drug-reimbursement that commissioners would like to consider, but they struggled to come up with a clear list of policies for consideration. MedPAC began talking about Medicare drug policy more than...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.